Douglas M. Lankler - 22 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)

Signature
/s/ Shanice A. Reid, by power of atty, for Douglas M. Lankler
Issuer symbol
PFE
Transactions as of
22 Feb 2025
Net transactions value
+$504,811
Form type
4
Filing time
25 Feb 2025, 19:05:31 UTC
Previous filing
16 Sep 2024
Next filing
03 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $2,589,310 +85,824 +58% $30.17 232,775 22 Feb 2025 Direct F1
transaction PFE Common Stock Tax liability $87,684 -3,334 -1.4% $26.30 229,441 22 Feb 2025 Direct F2, F3
transaction PFE Common Stock Tax liability $1,996,815 -76,565 -33% $26.08 152,876 22 Feb 2025 Direct F4, F5
holding PFE Common Stock 1,951 22 Feb 2025 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -85,824 -100% $0.000000 0 22 Feb 2025 Common Stock 85,824 $30.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 Price is the closing price of Pfizer common stock on February 21, 2025.
F4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Remarks:

dlxpoa24.htm